Biggest News Aggregation in the World
๐Ÿ“ฐ Andrew Hack News

Andrew Hack News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Andrew Hack. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Cambridge cancer drug startup Nuvalent raises $135 million

Cambridge cancer drug startup Nuvalent raises $135 million The new funding comes just four months after it was launched with $50 million. By Jonathan Saltzman Globe Staff,Updated May 11, 2021, 6:00 a.m. Email to a Friend James Porter is CEO of Cambridge biotech Nuvalent.Nuvalent Nuvalent, a Cambridge biotech working on precision cancer drugs, has raised another $135 million in venture capital just four months after the firm was launched with $50 million in financing. The startup is developing l...
New Zealand General New Zealand Christopher Turner James Porter Matthew Shair Bain Capital Life Sciences

Nuvalent Closes $135M Series B Financing

Nuvalent, Inc., a Cambridge, Mass.-based biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, closed a $135mย Series B financing. The round was led by Bain Capital Life Sciences with participation from sole founding investor, Deerfield Management, and additional new investors Fidelity Management and Research Company LLC, Wellington Management Company, Viking Global Investors, Janus Henderson Investors, Avoro Capital Advisors, Boxer Capital...
New Zealand General New Zealand United Kingdom Christopher Turner James Porter Bain Capital Life Sciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science